American Gene Technologies
Focus: American Gene Technologies is a public-stage gene therapy and immunotherapy company focused on lentiviral vector platforms for HIV cure, liver cancer, and rare disease applications. The company is headquartered in Rockville, MD and operates in a specialized niche of cell and gene therapy.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About American Gene Technologies
AI assessmentNot HiringNo open roles listed right now. Follow American Gene Technologies to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
6 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Peak
Approved product but appears to be an ancillary product rather than core gene therapy focus.
Products & Portfolio (1)
Help build intelligence for American Gene Technologies
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.